Status:
ACTIVE_NOT_RECRUITING
RHYTHMIA vs CARTO in Redo Ablation Procedures for Atrial Fibrillation
Lead Sponsor:
The Cleveland Clinic
Collaborating Sponsors:
Boston Scientific Corporation
Conditions:
Paroxysmal Atrial Fibrillation
Eligibility:
All Genders
18-90 years
Brief Summary
The MAP-AF study will compare RHYTHMIA vs CARTO in redo ablation of paroxysmal AF with assessment of both acute procedural profiles and clinical outcomes.
Detailed Description
Pulmonary venous conduction recovery is found in most patients undergoing redo ablation procedures for atrial fibrillation (AF). Identifying gaps in prior ablation lines is essential to achieve succes...
Eligibility Criteria
Inclusion
- Adult patients (18-90 years of age) undergoing redo ablation procedures for paroxysmal AF regardless of the systems or energy sources used during the pre-study ablation procedure(s).
- Paroxysmal AF: defined as AF terminating within 7 days of onset either spontaneously or with electrical or medical cardioversion.
Exclusion
- Persistent AF
- Prior cardiac surgery
- Patients with only AFL or AT as the documented recurrent arrhythmia after the pre-study AF ablation(s).
Key Trial Info
Start Date :
July 24 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2026
Estimated Enrollment :
49 Patients enrolled
Trial Details
Trial ID
NCT04835844
Start Date
July 24 2020
End Date
July 1 2026
Last Update
May 23 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cleveland Clinic
Cleveland, Ohio, United States, 44195